COVID-19 survivors frequently report lasting symptoms like fatigue and cognitive difficulties, affecting about one-third of those infected. Initially met with skepticism, the clinical community is now starting to recognize long-term COVID-19 (LTC) as a legitimate concern, particularly affecting individuals aged 30 to 49. Patients have reported repeated infections and significant challenges in work performance. Current treatment strategies mainly involve rehabilitation therapy, but increasing research is being conducted to better understand and address the issue of LTC.
Research data suggest that about one-third of COVID-19 survivors suffer from a variety of symptoms long after they were first infected.
The clinical community first met the long-term COVID-19 (LTC) cluster of symptoms with skepticism, asserting that patients were malingering.
Some studies reported that the highest impact of LTC was in people aged 30 to 49, challenging previous assumptions about affected demographics.
The current treatment approach is based mainly on rehabilitation therapy, while more research on long-term COVID-19 is beginning to emerge.
Collection
[
|
...
]